SCHEMBL18620784

SCHEMBL18620784

c1ccc(-n2c3ccccc3c3ccc4c5ccc6oc7ccccc7c6c5n(-c5nc(-c6ccc7ccccc7c6)c6ccccc6n5)c4c32)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
MAPT P10636 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
LMNA P02545 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAPK1 P28482 2/20 0.32
HTT P42858 1/20 0.32
L3MBTL1 Q9Y468 4/20 0.31
ATM Q13315 2/20 0.31
POLB P06746 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22192645 0.96 SIRT2 (0.32) SIRT2SIRT1KDM4EALDH1A1HPGD
SCHEMBL18619125 0.94 SIRT2 (0.31) SIRT2SIRT1KDM4EALDH1A1HPGD
SCHEMBL18619101 0.94 SIRT2 (0.31) SIRT2SIRT1KDM4EALDH1A1HPGD
SCHEMBL18621329 0.93 SIRT2 (0.32) SIRT2SIRT1KDM4EALDH1A1HPGD
SCHEMBL18621253 0.92 L3MBTL1 (0.31) SIRT2SIRT1KDM4EALDH1A1HPGD
SCHEMBL18621257 0.92 L3MBTL1 (0.31) SIRT2SIRT1KDM4EALDH1A1HPGD
SCHEMBL22192457 0.91 HPGD (0.35) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL18619088 0.91 SIRT2 (0.32) SIRT2SIRT1KDM4EALDH1A1HPGD
SCHEMBL18620440 0.91 HPGD (0.37) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL18620783 0.91 ALDH1A1 (0.39) KDM4EALDH1A1HPGDNPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10703762-B2 Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus IDEMITSU KOSAN CO., LTD. (JP) 2020-07-07 US disclosed
WO-2017038728-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2017-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10703762-B2 Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus PIEZO1, OR10J3, EPCAM SIRT2 3158/4885SIRT1 2981/4885KDM4E 3529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.